Lightning Round: Qualcomm, GenCorp & more
Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.

Qualcomm (QCOM): It's a buy, said Cramer. Wall Street is addicted to this stock. I'd buy half a position now and the other half on negative news.



PTC Therapeutics (PTCT): I think biotechs deserve a long hard look after Merck acquired hepatitis C maker Idenix for $24.50 per share, more than three times Idenix's Friday closing price of $7.23, Cramer said.